Skip to main content
. 2010 Aug 15;137(16):2633–2642. doi: 10.1242/dev.053181

Fig. 4.

Fig. 4.

Twist binding sites are required for Notch activation of argosNRE. (A) Response of the indicated enhancers to NICD in transient transfection assays in DmD8 cells, expressed as fold change (dark-grey bars) relative to expression levels in the absence of Notch (light-grey bars). Mutating Twi binding sites as indicated abolishes aosNRE responsiveness. (B,C) In vivo, mutations of the same sites lead to a decrease in expression (C) compared with the control enhancer (B).